Science Explorer Back to mapMap
Discussion
Researcher · Università degli Studi del Piemonte Orientale “Amedeo Avogadro” · Italy

Oscar Alabiso

Oscar Alabiso publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Cancer Research, on topics such as Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology and Lung Cancer Treatments and Mutations.

ORCID 0000-0003-3635-1710 OpenAlex
World rank
#1,114,203
of 7,710,434 ranked researchers
Rank in Italy
#35,239
of 242,206
Works
124
Citations
2.7k
Citations per work
21.5
h-index
29
i10-index 49Top 12% in Oncology
Oscar Alabiso

What does Oscar Alabiso research?

Oscar Alabiso's work is mostly in Medicine (56%), Biochemistry, Genetics and Molecular Biology (7%), Economics, Econometrics and Finance (4%).

Health Sciences: 70 works · 56.2% of their workMedicine: 70 works · 56.2% of their workOncology: 38 works · 30.6% of their workPulmonary and Respiratory Medicine: 21 works · 16.6% of their workSurgery: 7 works · 5.3% of their workEpidemiology: 5 works · 3.7% of their workEverything else: 40 works · 32.5% of their workLife Sciences: 9 works · 7.0% of their workBiochemistry, Genetics and Molecular Biology: 9 works · 7.0% of their workCancer Research: 9 works · 7.0% of their workSocial Sciences: 5 works · 4.3% of their workEconomics, Econometrics and Finance: 5 works · 4.3% of their workEconomics and Econometrics: 5 works · 4.3% of their workTHEIR WORKOscar Alabiso124works
Life Sciences7%Health Sciences56%Social Sciences4%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine7056.2%
  2. Everything else4032.5%
    1. Biochemistry, Genetics and Molecular Biology97.0%
    1. Economics, Econometrics and Finance54.3%
  1. 1Oncology31% of their works
  2. 2Pulmonary and Respiratory Medicine17% of their works
  3. 3Cancer Research7% of their works
  4. 4Surgery5% of their works
  5. 5Economics and Econometrics4% of their works
  6. 6Epidemiology4% of their works

Research topics

Which keywords describe Oscar Alabiso's research?

The keywords of their largest research topics: Chemotherapy, Molecular Subtypes, Cetuximab, KRAS Mutations, Chemotherapy-Induced Peripheral Neuropathy, Taxanes, Clinical Practice Guidelines and EGFR Mutations.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Chemotherapy443 topics
  2. Molecular Subtypes332 topics
  3. Cetuximab261 topic
  4. KRAS Mutations261 topic
  5. Chemotherapy-Induced Peripheral Neuropathy191 topic
  6. Taxanes191 topic
  7. Clinical Practice Guidelines172 topics
  8. EGFR Mutations171 topic
  9. Targeted Therapy171 topic
  10. Radiotherapy152 topics
  11. Breast Cancer101 topic
  12. HER2101 topic
  13. Hepatocellular Carcinoma101 topic
  14. Liver Cancer101 topic
  15. CT Screening81 topic
  16. Lung Cancer81 topic
  17. Biliary Tract Cancer71 topic
  18. Breast Tumours71 topic
  19. Cholangiocarcinoma71 topic
  20. Gene Expression71 topic

Where does Oscar Alabiso work?

Oscar Alabiso's main affiliation in the publication record is Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, Italy.

How many publications and citations does Oscar Alabiso have?

OpenAlex counts 124 works and 2,660 citations for Oscar Alabiso, an h-index of 29, ranking #1,114,203 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Oscar Alabiso. Posts are plain text and can be reported.